Drug Trial Radar · NCT03857542
A Phase 3 Efficacy Study of Pilocarpine HCl Ophthalmic Solution (AGN-190584) in Participants With Presbyopia
Last checked: Nov 19, 2026Latest source record: Dec 29, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
427
Actual
Start
Mar 1, 2019
Primary completion
Sep 10, 2020
Study completion Sep 10, 2020
Sponsor
- Lead sponsor
- AllerganAbbVie (ABBV)
- Sponsor type
- Industry
- First posted
- Feb 28, 2019
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 40 years, up to 55 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This clinical study will evaluate pilocarpine hydrogen chloride (HCl) ophthalmic solution (AGN-190584) in an expanded participant population to establish efficacy, safety, and tolerability versus the vehicle-control when administered, over a 30-day study intervention period, once daily bilaterally in participants with presbyopia.
Conditions
- Presbyopia
Interventions
Pilocarpine HCl Ophthalmic SolutionDrug
Pilocarpine HCl ophthalmic solution 1.25%, one drop in each eye, once daily, for up to 30 days.
VehicleOther
Vehicle, one drop in each eye, once daily, for up to 30 days.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Gaining 3 Lines or More in Mesopic, High-contrast, Binocular DCNVA, Without Losing More Than 5 Letters of Mesopic, High-Contrast, Binocular CDVA With the Same Refractive Correction at Day 30, Hour 3Time frame: Baseline (Day 1) to Day 30 (Hour 3)
Locations
35 sites in 1 country. Site status is shown where the registry gives one.
Eye Center South
Dothan, Alabama
M&M Eye Institute
Prescott, Arizona
Walman Eye Center
Sun City, Arizona
Milton M. Hom, OD, FAAO
Azusa, California
Global Research Management
Glendale, California
Advanced Vision Care
Los Angeles, California
North Valley Eye Medical Group, Inc.
Mission Hills, California
Eye Research Foundation
Newport Beach, California
Corneal Consultants of Colorado
Littleton, Colorado
Benjamin Knox Lambright, MD
Crystal River, Florida
South Florida Vision Center
Fort Lauderdale, Florida
Bowden Eye Associates
Jacksonville, Florida
Mid Florida Eye Center
Mt. Dora, Florida
Newsom Eye & Laser Center
Sebring, Florida
Clayton Eye Center
Morrow, Georgia
The Midwest Center for Sight
Des Plaines, Illinois
Jacksoneye
Lake Villa, Illinois
Kannarr Eye Care
Pittsburg, Kansas
Heart of America Eyecare
Shawnee Mission, Kansas
Cincinnati Eye Institute
Edgewood, Kentucky
Chu Laser Eye Institute
Bloomington, Minnesota
Silverstein Eye Centers
Kansas City, Missouri
Moyes Eye Center
Kansas City, Missouri
Tekwani Vision Center
St Louis, Missouri
Amel Youssef, OD
Las Vegas, Nevada
Debry Medical Services PC
Las Vegas, Nevada
Bucci Laser Vision
Wilkes-Barre, Pennsylvania
Waring Vision Institute
Mt. Pleasant, South Carolina
University Eye Surgeons
Maryville, Tennessee
Total Eye Care, PA
Memphis, Tennessee
Keystone Research ltd. at Texan Eye
Austin, Texas
The Cataract and Glaucoma Center
El Paso, Texas
Texas Eye & Laser Ctr
Hurst, Texas
Benjamin Travis Dastrup, MD
Ogden, Utah
Vision Consultants and Surgeons
Falls Church, Virginia
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.